{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Agatolimod_Sodium",
  "nciThesaurus": {
    "casRegistry": "541547-35-7",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "The tricosasodium salt of a synthetic 24-mer oligonucleotide containing 3 CpG motifs with potential antineoplastic and immunostimulatory activity. Agatolimod selectively targets Toll-like receptor 9 (TLR9), thereby activating dendritic and B cells and stimulating cytotoxic T cell and antibody responses against tumor cells bearing tumor antigens.",
    "fdaUniiCode": "I4Z5C8FM6H",
    "identifier": "C28580",
    "preferredName": "Agatolimod Sodium",
    "semanticType": "Nucleic Acid, Nucleoside, or Nucleotide",
    "subclassOf": [
      "C2139"
    ],
    "synonyms": [
      "(3'-5')d(P-thio)(T-C-G-T-C-G-T-T-T-T-G-T-C-G-T-T-T-T-G-T-C-G-T-T) Tricosasodium Salt",
      "AGATOLIMOD SODIUM",
      "Agatolimod Sodium",
      "CpG 7909",
      "PF-3512676",
      "ProMune"
    ]
  }
}